Small-cell lung cancer transformation approximately four years after surgery and adjuvant therapy for EGFR-mutant lung adenocarcinoma: a case report
Background Transformation of epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) to small-cell lung cancer (SCLC) is a recognized mechanism of acquired resistance to EGFR tyrosine kinase inhibitors (EGFR-TKIs) and is associated with poor clinical outcomes. The optimal treatment strategy for transformed SCLC remains uncertain. Case presentation We report a case of EGFR exon 21 mutant lung adenocarcinoma in a 48-year-old woman who developed SCLC transformation approximately 4 years after surgery and postoperative adjuvant therapy. Clinical course and treatment Following the identification of SCLC, the patient received multiple treatment regimens, including platinum–etoposide chemotherapy, osimertinib, and local radiotherapy. A subsequent biopsy in 2019 again demonstrated small cell carcinoma. Peripheral blood molecular testing identified EGFR L858R, TP53 p.C242F, and RB1 c.607 + 1G > A-alterations. The patient died of respiratory failure in January 2020, approximately 6 years after the initial diagnosis and 20 months after the identification of SCLC transformation. Conclusion This case illustrates the clinical challenges of SCLC transformation in EGFR-mutant lung adenocarcinoma after a prolonged postoperative interval. The longitudinal treatment course and molecular findings provide additional clinical observations relevant to the management of transformed SCLC, although the contribution of individual treatments cannot be determined from a single case.
Authors
- Hong Wang (ORCID: https://orcid.org/0000-0002-0034-0270)
- Boyu Qin
- Jing Zhao
- Hao Zhang
- Lin Yang
Institutions
- Chinese PLA General Hospital (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2026-11-12
- DOI
- https://doi.org/10.3389/fmed.2026.1982251
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00